MarketsStocksJUBLPHARMA
JU

Jubilant Pharmova Ltd

NSE: JUBLPHARMABSE: 530019Healthcare
Download Research Report7-page PDF
945.95
-2.84%
NSE · auto-updates while market open
Prev Close
₹1,140.00
Day High
₹972.00
Day Low
₹944.60
Mkt Cap
₹14,957 Cr
P / E
37.6
P / B
2.1
ROE
6.0%
52W High
₹1,248.00
52W Low
₹786.05
Key Metrics
Market Cap
₹14,957 Cr
P / E
37.63
P / B
2.11
EV / EBITDA
14.44
ROCE
8.7%
ROE
6.0%
Debt / Equity
0.45
Book Value
₹448.91
EPS
₹25.15
Div Yield
0.5%
Face Value
₹1
Promoter Holding
47.7%
Revenue · ₹ Cr
9.2k
FY20
6.1k
FY21
6.1k
FY22
6.3k
FY23
670
FY24
7.2k
FY25
8.3k
FY26
Net Profit · ₹ Cr
898
836
413
7
836
398
-65
FY20FY21FY22FY23FY24FY25FY26
EPS · ₹ per share
₹56.4
₹52.5
₹26.0
₹4.9
₹53.0
₹25.1
₹-3.8
FY20FY21FY22FY23FY24FY25FY26
P / E Ratio · price ÷ TTM EPS
09418828266270-11Jun 21Feb 23Oct 24Jun 26
P/E 38.1×Median 30.0×TTM EPS
Q1 2026 snapshot
Sales
₹2.31K Cr
Operating profit
-
OPM
-
Net profit
₹119 Cr
EPS
₹7.55
Scorecard · 7 axes
Quality
Weak
38/100
Valuation
Avg
37.6×
Growth
Bad
-4.4%
Profitability
Weak
7.3%
Performance
Bad
-14.8%
Entry Point
Good
76%
Red Flags
Strong
0 flags
Shareholding Pattern
47.7%Promoter
Promoter47.7%
FII15.9%
DII11.6%
Public24.8%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue1,821.71,940.71,912.71,976.22,1432,313.7
Net Profit100.7151.3102.5119.955.8119.3
NPM %5.5%7.8%5.4%6.1%2.6%5.2%
AlertPre-trade